American Oncology Network, INC 8-K filings

American Oncology Network, Inc. acquired the assets of Central Georgia Cancer Care for $13.3 million, including cash and a promissory note.

American Oncology Network has completed the acquisition of Central Georgia Cancer Care for approximately $13.3 million, expanding its presence in Georgia.

American Oncology Network's 2024 Annual Meeting saw the election of two Class I Directors and the ratification of PricewaterhouseCoopers LLP as the company's auditor for the 2024 fiscal year.

American Oncology Network has entered into a Stockholders Agreement with AEA Growth Management, providing shareholder protections if AEA's ownership reaches 40% of the company's voting power.

American Oncology Network has appointed David Afshar as Chief Financial Officer and Chief Operating Officer, effective immediately.

American Oncology Network has announced its decision to voluntarily delist its Class A common stock and warrants from the Nasdaq Capital Market.

American Oncology Network (AONC) announced a 20% increase in revenue for the first quarter of 2024, driven by patient encounter growth, but also reported a significant increase in net loss and a decrease in adjusted EBITDA.

American Oncology Network has announced the resignation of its principal financial officer, David H. Gould, effective May 17, 2024, and the appointment of David Afshar as interim replacement.

American Oncology Network has appointed William J. Valle as a new independent Class I Director, effective immediately.

American Oncology Network and Ascend Technologies Group have partnered to launch Meaningful Insights Biotech Analytics (MiBA), a healthcare technology company leveraging data analytics to improve cancer care.

American Oncology Network (AON) announced a significant 11.3% revenue increase for fiscal year 2023, driven by patient encounter growth, but reported a net loss due to various factors including transaction expenses and billing system transition costs.